Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
02/2012
02/16/2012US20120041028 Benzimidazoles which have activity at m1 receptor and their uses in medicine
02/16/2012US20120041027 Benzimidazoles which have activity at m1 receptor and their uses in medicine
02/16/2012US20120041026 (r)-4-((4-((4-(tetrahydrofuran-3-yloxy)benzo[d]isoxazol-3-yloxy)methyl)piperidin-1-yl)methyl)tetrahydro-2h-pyran-4-ol, a partial agonist of 5-ht4 receptors
02/16/2012US20120041025 Dihydrolipoic Acid Derivatives Comprising Nitric Oxide and Therapeutic Uses Thereof
02/16/2012US20120041024 Quinolyl amines as kinase inhibitors
02/16/2012US20120041023 Small molecule activators of mitochondrial function
02/16/2012US20120041022 Process for preparing enantiomerically enriched alkaloids
02/16/2012US20120041021 Process for Preparing a Semi-Solid Delivery Vehicle and Pharmaceutical Compositions
02/16/2012US20120041020 Methods of Treatment Utilizing Semi-Solid Pharmaceutical Compositions
02/16/2012US20120041019 Protease inhibitors
02/16/2012US20120041018 Octahydrobenzoisoquinoline modulators of dopamine receptors and uses therefor
02/16/2012US20120041017 Pyridocarbazole type compounds and applications thereof
02/16/2012US20120041016 11-Aza, 11-Thia and 11-Oxa Sterol Compounds and Compositions
02/16/2012US20120041015 Method and composition for treating nodulocystic and conglobate acne vulgaris
02/16/2012US20120041014 Methods of Converting a Patient's Treatment Regimen from Intravenous Administration of an Opioid to Oral Co-Administration of Morphine and Oxycodone Using a Dosing Algorithm to Provide Analgesia
02/16/2012US20120041013 New azacyclic compounds
02/16/2012US20120041012 Substituted spirocyclic amines useful as antidiabetic compounds
02/16/2012US20120041011 Substituted benzofused derivatives and their use as vanilloid receptor ligands
02/16/2012US20120041010 Pharmaceutical combination of (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl] (3r,5s)-3,5-dihydroxyhept-6-enoic acid and candesartan
02/16/2012US20120041008 4-Phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-Based Compounds and Methods of Their Use
02/16/2012US20120041007 Cdk inhibitor salts
02/16/2012US20120041006 Compositions for Raising Uric Acid Levels and Methods of Using the Same
02/16/2012US20120041005 Use of alkanoyl l-carnitine for the treatment of erectile dysfunction
02/16/2012US20120041004 Fused pyrimidine-dione derivatives as trpai modulators
02/16/2012US20120041003 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
02/16/2012US20120041002 Substituted pyrazolo [1,5-a] pyrimidines as metabotropic glutamate antagonists
02/16/2012US20120041001 Carbonylamino-derivatives as novel inhibitors of histone deacetylase
02/16/2012US20120041000 Imidazo [1,2-a]pyridine derivatives as fgfr kinase inhibitors for use in therapy
02/16/2012US20120040999 P38 kinase inhibiting agents
02/16/2012US20120040998 2-alkyl piperidine mglur5 receptor modulators
02/16/2012US20120040997 Vinyl-aryl derivatives for inflammation and immune-related uses
02/16/2012US20120040996 3-benzofuranyl-indol-2-one derivatives substituted at the 3 position, preparation thereof, and therapeutic use thereof
02/16/2012US20120040995 Design, synthesis and evaluation of procaspase activating compounds as personalized anti-cancer drugs
02/16/2012US20120040994 THERAPEUTIC AGENT FOR GLAUCOMA COMPRISING Rho KINASE INHIBITOR AND PROSTAGLANDIN
02/16/2012US20120040993 Neuroprotective multifunctional compounds and pharmaceutical compositions comprising them
02/16/2012US20120040992 Oligooxopiperazines and methods of making and using them
02/16/2012US20120040991 3-azabicyclo [4.1.0] heptanes used as orexin antagonists
02/16/2012US20120040990 Indol-3-y-carbonyl-piperidin and piperazin-derivatives
02/16/2012US20120040989 2-hydroxyethyl-1h-quinolin-2-one derivatives and their azaisosteric analogues with antibacterial activity
02/16/2012US20120040988 DERIVATIVES OF 6,7-DIHYDRO-3H-OXAZOLO[3,4-a]PYRAZINE-5,8-DIONE
02/16/2012US20120040987 Derivatives of 6-(6-nh-substituted-triazolopyridazine-sulfanyl) benzothiazoles and benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors
02/16/2012US20120040986 Omega carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
02/16/2012US20120040985 Triazole and imidazole derivatives for use as tgr5 agonists in the treatment of diabetes and obesity
02/16/2012US20120040984 Thiadiazole and oxadiazole derivatives, preparation thereof and therapeutic use thereof
02/16/2012US20120040983 Phthalazine Compounds as P38 Map Kinase Modulators and Methods of Use Thereof
02/16/2012US20120040982 Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
02/16/2012US20120040981 Thienopyrimidine as cdc7 kinase inhibitors
02/16/2012US20120040980 Quinazolinone compounds
02/16/2012US20120040979 Imidazo[1,2-b]pyridazines, processes, uses, intermediates and compositions
02/16/2012US20120040978 Heterocyclic Fused Cinnoline M1 Receptor Positive Allosteric Modulators
02/16/2012US20120040977 Inhibitors of hcv ns5a
02/16/2012US20120040976 Small molecule immunomodulators for alzheimer's disease
02/16/2012US20120040975 Bridged bicyclic heterocycle derivatives and methods of use thereof
02/16/2012US20120040974 Mif modulators
02/16/2012US20120040973 Derivatives of [1,3]oxazin-2-one useful for the treatment of metabolic diseases such as lipid disorders
02/16/2012US20120040972 Dual modulators of 5ht2a and d3 receptors
02/16/2012US20120040971 Benzodiazepinone compounds useful in the treatment of skin conditions
02/16/2012US20120040970 Intranasal delivery system for dantrolene
02/16/2012US20120040969 N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
02/16/2012US20120040968 Diamino heterocyclic carboxamide compound
02/16/2012US20120040967 Pyrazin-2-yl-pyridin-2-yl-amine and pyrazin-2-yl-pyrimidin-4-yl-amine Compounds and Their Use
02/16/2012US20120040966 Anti-viral compounds, treatment, and assay
02/16/2012US20120040965 Substituted azepino[4,3-b]indoles, pharmacological composition and a method for the production and use thereof
02/16/2012US20120040964 N-substituted piperidines and their use as pharmaceuticals
02/16/2012US20120040962 Fused ring inhibitors of hepatitis c
02/16/2012US20120040961 Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders
02/16/2012US20120040960 4-azetidinyl-1-phenyl-cyclohexane antagonists of ccr2
02/16/2012US20120040959 8-methoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-infective agents
02/16/2012US20120040958 Indole carboxamides as ikk2 inhibitors
02/16/2012US20120040957 Novel Bicyclic Antibiotics
02/16/2012US20120040956 Inhibitors of hif-1 protein accumulation
02/16/2012US20120040955 Fluoro substituted pyrimidine compounds as jak3 inhibitors
02/16/2012US20120040954 Novel anti-inflammatory agents
02/16/2012US20120040953 Compounds for the Treatment of Metabolic Disorders
02/16/2012US20120040952 Azetidines as histamine h3 receptor antagonists
02/16/2012US20120040951 Heteroaryl compounds useful as raf kinase inhibitors
02/16/2012US20120040950 Isoindolinone inhibitors of phosphatidylinositol 3-kinase
02/16/2012US20120040949 Inhibitors of Bruton's Tyrosine Kinase
02/16/2012US20120040948 Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
02/16/2012US20120040947 Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
02/16/2012US20120040946 Medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and a process to make it
02/16/2012US20120040945 Use of a Glucocorticoid Composition for the Treatment of Severe and Uncontrolled Asthma
02/16/2012US20120040944 medicinal cream made using mometasone furoate and chitosan and a process to make the same
02/16/2012US20120040943 Combinations comprising antimuscarinic agents and beta-adrenergic agonists
02/16/2012US20120040942 Novel bronchodilating diazaheteroaryls
02/16/2012US20120040941 5-(2--1-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one and its use in the treatment of pulmonary diseases
02/16/2012US20120040940 Combination of pilocarpin and methimazol for treating charcot-marietooth disease and related disorders
02/16/2012US20120040939 Medicinal use of 5-benzylaminosalicylic acid derivative or its salt
02/16/2012US20120040938 Glucocorticoid receptor alleles and uses thereof
02/16/2012US20120040937 Compounds for the treatment of proliferative disorders
02/16/2012US20120040936 Cyclic compound having substituted phenyl group
02/16/2012US20120040935 Compositions useful as inhibitors of voltage-gated ion channels
02/16/2012US20120040934 Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
02/16/2012US20120040933 9-(piperazinylalkyl) carbazoles as bax-modulators
02/16/2012US20120040932 Cyclic boronic acid ester derivatives and therapeutic uses thereof
02/16/2012US20120040931 Novel organopolysiloxane and cosmetic containing the same
02/16/2012US20120040930 Tetracyclic terpene series compounds, methods for preparing same, uses thereof as medicines and pharmaceutical compounds containing same
02/16/2012US20120040929 Food composition comprising glucosamine
02/16/2012US20120040928 Methods and compositions for inhibiting cellular proliferation and surgical adhesion
02/16/2012US20120040927 Medicinal antifungal and steroid cream incorporating a biopolymer and a process to make it.
1 ... 1348 1349 1350 1351 1352 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 ... 7860